Cortacare

RSS

hydrocortisone aceponate

Authorised
This medicine is authorised for use in the European Union.

Overview

Cortacare is a corticosteroid veterinary medicine used to treat inflamed and itchy skin conditions in dogs. It contains the active substance hydrocortisone aceponate.

Cortacare is a ‘hybrid medicine’. This means that it is similar to a ‘reference medicine’ containing the same active substance. The reference medicine for Cortacare is Cortavance.

This EPAR was last updated on 28/09/2018

Authorisation details

Product details
Name
Cortacare
Agency product number
EMEA/V/C/004689
Active substance
hydrocortisone aceponate
International non-proprietary name (INN) or common name
hydrocortisone aceponate
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QD07AC
Publication details
Marketing-authorisation holder
Ecuphar
Revision
0
Date of issue of marketing authorisation valid throughout the European Union
27/08/2018
Contact address
Legeweg 157-i B-8020
Oostkamp 8020
Oostkamp
Belgium

Product information

22/06/2018 Cortacare - EMEA/V/C/004689 -

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Corticosteroids
  • Dermatological preparations

Therapeutic indication

For symptomatic treatment of inflammatory and pruritic dermatoses in dogs. 

Assessment history

How useful was this page?

Add your rating
Average
2 ratings